|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$22,000
|
N/A
|
National Institutes of Health
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$666
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$834,152
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,857,052
|
$742,855
|
Custer, Mary
|
CCR (NCI)
|
|
Childrens Oncology Group Statistics and Data Center
|
5U10CA180899-05
|
$7,738,106
|
$773,811
|
DEVIDAS, MEENAKSHI
|
UNIVERSITY OF FLORIDA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$64,202
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$250,739
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-39
|
$6,063,271
|
$181,898
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,352,849
|
$428,228
|
Camphausen, Kevin
|
CCR (NCI)
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
$421,876
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$3,561,926
|
$178,096
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$174,656
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Evaluating How Tobacco Control Policies are Shaping the Nicotine Delivery Market
|
5P01CA200512-02
|
$3,033,680
|
|
CUMMINGS, KENNETH
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Genomics of Acute Myelogenous Leukemia
|
5P01CA101937-14
|
$2,917,422
|
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA016087-37
|
$2,636,133
|
|
NEEL, BENJAMIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$900,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Statistical Methods for Integrative Genomics in Cancer
|
5P01CA196569-02
|
$2,440,285
|
|
THOMAS, DUNCAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$620,405
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-05S1
|
$2,256,906
|
$90,276
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
|
5U54CA193461-03
|
$2,245,877
|
|
MICHOR, FRANZISKA
|
DANA-FARBER CANCER INST
|
|
Colon Cancer Family Registry Cohort
|
5UM1CA167551-05
|
$2,220,620
|
|
HAILE, ROBERT
|
STANFORD UNIVERSITY
|
|
Topology of Cancer Evolution and Heterogeneity
|
5U54CA193313-03
|
$2,087,754
|
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology
|
5U54CA193417-03
|
$2,076,805
|
|
DISCHER, DENNIS
|
UNIVERSITY OF PENNSYLVANIA
|
|
Statistical Methods for Cancer Clinical Trials
|
5P01CA142538-08
|
$2,066,666
|
|
KOSOROK, MICHAEL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Molecular Biology and Genetics of Human Tumor Viruses
|
5P01CA022443-40
|
$2,063,652
|
|
LAMBERT, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$197,894
|
Gress, Ronald
|
CCR (NCI)
|
|
Development of Novel Cancer Therapeutics by Targeting Sphingolipid Signaling
|
5P01CA203628-02
|
$1,780,770
|
|
OGRETMEN, BESIM
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-03
|
$1,762,723
|
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,671,202
|
$250,680
|
Pastan, Ira
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$30,758
|
Barr, Frederic
|
CCR (NCI)
|
|
Molecular pathoepidemiology of contralateral breast cancer
|
1R01CA206464-01A1
|
$1,438,154
|
|
MALONE, KATHLEEN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
|
5P01CA163222-05
|
$1,407,704
|
|
FISHER, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,382,902
|
$691,451
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
1P01CA214091-01
|
$1,356,357
|
$311,962
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
|
5U01CA152990-07
|
$1,356,082
|
|
SKATES, STEVEN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
5P01CA214091-02
|
$1,312,028
|
$301,766
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
DNA repair
|
ZIA BC 010283
|
$1,309,141
|
$222,554
|
Nussenzweig, Andre
|
CCR (NCI)
|
|
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
|
5U10CA180798-04
|
$1,221,450
|
|
MANNEL, ROBERT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$219,287
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Discovery and verification of novel biomarkers of colorectal cancer recurrence
|
5R01CA189184-03
|
$1,061,342
|
|
LI, CHRISTOPHER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids
|
5U01CA199241-02
|
$1,026,181
|
|
KUO, CALVIN
|
STANFORD UNIVERSITY
|
|
Smartphone for molecular cancer diagnostic in Africa
|
4UH3CA202637-03
|
$973,275
|
$486,638
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
|
5U01CA152662-07
|
$970,519
|
|
MASSION, PIERRE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Toward a screening designation for SoftVue: A multi-center clinical trial in support of Pre-Market Approval.
|
5R44CA165320-05
|
$962,653
|
|
DURIC, NEBOJSA
|
DELPHINUS MEDICAL TECHNOLOGIES, INC.
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
5R35CA197452-03
|
$904,402
|
|
FLORES, ELSA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
NCI NCTN-Network Lead Academic Site at UPCI
|
5U10CA180844-04
|
$898,445
|
|
BRUFSKY, ADAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Hemodynamic Noninvasive Skin Cancer Diagnostics
|
5R44CA203038-03
|
$896,930
|
|
CHACHISVILIS, MIRIANAS
|
VERISKIN, INC.
|
Total relevant funding to Hodgkins disease for this search: $13,978,699
|